Join
Live feed
·
PRReleasevia Quantisnow
Theravance Biopharma Inc. logo

THERAVANCE BIOPHARMA ENTERS INTO DEFINITIVE AGREEMENT TO BE ACQUIRED BY ZYMEWORKS FOR $17.00 PER SHARE IN CASH PLUS A CONTINGENT VALUE RIGHT

ByQuantisnow·Wall Street's wire, on your screen.
TBPH· Theravance Biopharma Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TBPH (Theravance Biopharma Inc.) and more on Quantisnow.